LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to ...
Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa® System - the world's first and only smart cochlear implant system. The new Cochlear™ Nucleus® ...
Individuals with UHL/SSD can now seek treatment with a cochlear implant from Cochlear to hear with both ears. Cochlear Limited obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...
Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...
Thank you for standing by. And welcome to the Cochlear Limited FY 2024 Results, Analyst and Media Briefing. All participants are in a listen-only mode. There will be a presentation followed by a ...
NEW YORK, Aug. 8, 2024 /PRNewswire/ -- The global cochlear implants market size is estimated to grow by USD 975.3 million from 2024-2028, according to Technavio. The market is estimated to grow at a ...
SYDNEY, Sept 12 (Reuters) - Australian hearing implant maker Cochlear Limited said on Monday it was undertaking a voluntary recall of the unimplanted Nucleus CI500 implant range, with the financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results